NASDAQ:MAXY - Maxygen Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Maxygen (NASDAQ:MAXY)

Maxygen, Inc. (Maxygen) is a biotechnology company focused on the development of its MAXY-G34 product candidate. MAXY-G34 is a pegylated, granulocyte colony stimulating factor (G-CSF), for the treatment of chemotherapy-induced neutropenia and acute radiation syndrome (ARS). On May 16, 2011, Astellas Pharma Inc. (Astellas) acquired the Company's interests in Perseid Therapeutics LLC, the Company's former subsidiary, which included all of the Company's research and development operations. As a result of the transaction, the Company has reclassified the operating results of Perseid, as well as any related business activities, to discontinued operations. The Company's wholly owned subsidiaries include Maxygen Holdings (U.S.), Inc., Maxygen ApS and Maxygen Holdings, Inc., and its majority owned subsidiary, Maxygen Holdings LLC.

Receive MAXY News and Ratings via Email

Sign-up to receive the latest news and ratings for MAXY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryBiotechnology
SectorN/A
SymbolNASDAQ:MAXY
CUSIP57777610
Phone+1-650-2412292

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Maxygen (NASDAQ:MAXY) Frequently Asked Questions

What is Maxygen's stock symbol?

Maxygen trades on the NASDAQ under the ticker symbol "MAXY."

Has Maxygen been receiving favorable news coverage?

Media coverage about MAXY stock has trended somewhat positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Maxygen earned a coverage optimism score of 0.10 on Accern's scale. They also assigned media coverage about the biotechnology company an impact score of 47.11 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of Maxygen?

Shares of MAXY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Maxygen?

Maxygen's mailing address is 725 San Aleso Ave Ste 2, SUNNYVALE, CA 94085-1400, United States. The biotechnology company can be reached via phone at +1-650-2412292.


MarketBeat Community Rating for Maxygen (MAXY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  23 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  53
MarketBeat's community ratings are surveys of what our community members think about Maxygen and other stocks. Vote "Outperform" if you believe MAXY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MAXY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Maxygen (NASDAQ:MAXY) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 5/21/2016 forward)

Earnings

Maxygen (NASDAQ:MAXY) Earnings History and Estimates Chart

Earnings by Quarter for Maxygen (NASDAQ:MAXY)

Maxygen (NASDAQ MAXY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/7/2013Q2 2013($0.12)ViewN/AView Earnings Details
5/3/2013Q1 2013($0.08)ViewN/AView Earnings Details
3/12/2013Q4 2012($0.06)ViewN/AView Earnings Details
11/6/2012Q312($0.08)($0.10)ViewN/AView Earnings Details
8/7/2012Q2 2012($0.09)($0.11)ViewN/AView Earnings Details
5/7/2012Q1 2012($0.09)($0.09)ViewN/AView Earnings Details
3/8/2012Q4 2011($0.08)($0.06)ViewN/AView Earnings Details
11/7/2011Q3 2011($0.08)($0.08)ViewN/AView Earnings Details
8/8/2011Q2 2011($0.11)($0.05)ViewN/AView Earnings Details
5/5/2011Q1 2011($0.11)($0.11)ViewN/AView Earnings Details
3/8/2011Q4 2010($0.07)($0.11)ViewN/AView Earnings Details
11/4/2010Q3 2010($0.06)($0.02)ViewN/AView Earnings Details
8/4/2010Q2 2010$0.05ViewN/AView Earnings Details
5/6/2010Q1 2010($0.06)ViewN/AView Earnings Details
3/11/2010Q4 2009($0.10)ViewN/AView Earnings Details
11/5/2009Q3 2009($0.25)ViewN/AView Earnings Details
8/6/2009Q2 2009($0.20)($0.15)ViewN/AView Earnings Details
5/11/2009Q1 2009($0.24)($0.03)ViewN/AView Earnings Details
2/10/2009Q4 2008($0.30)($0.18)ViewN/AView Earnings Details
11/4/2008Q3 2008$1.64$2.14ViewN/AView Earnings Details
7/31/2008Q2 2008($0.37)($0.43)ViewN/AView Earnings Details
5/6/2008Q1 2008($0.39)($0.37)ViewN/AView Earnings Details
2/12/2008Q4 2007($0.35)($0.31)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Maxygen (NASDAQ:MAXY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Maxygen (NASDAQ MAXY) Insider Trading and Institutional Ownership History

Insider Trading History for Maxygen (NASDAQ:MAXY)

Maxygen (NASDAQ MAXY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Maxygen (NASDAQ MAXY) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Maxygen (NASDAQ:MAXY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Maxygen (NASDAQ:MAXY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Maxygen (NASDAQ MAXY) Stock Chart for Monday, May, 21, 2018

Loading chart…

This page was last updated on 5/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.